MYEZOM BORTEZOMIB 2 MG INJECTION

Get a Price/Quote

MYEZOM BORTEZOMIB 2 MG INJECTION Specification

Origin of Medicine
Allopathic

Dosage Form
Lyophilized Powder for Injection

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Bortezomib 2 mg

Indication
For the treatment of Multiple Myeloma and Mantle Cell Lymphoma

Drug Type
Prescription Only

Ingredients
Bortezomib

Physical Form
Injection

Function

Recommended For
Multiple Myeloma, Mantle Cell Lymphoma

Dosage
2 mg per vial, as prescribed by physician

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light

MYEZOM BORTEZOMIB 2 MG INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

About MYEZOM BORTEZOMIB 2 MG INJECTION

Myezom

This medication is a cancer chemotherapy drug used to treat certain types of tumors like multiple myeloma, mantle cell lymphoma. It blocks certain proteins which helps to slow the growth and spread of the cancer Available as: 2 Mg & 3.5 Mg

Specification

Product Name: Myezom
Contains: Bortezomib
Form: Vial
Strength:2 Mg & 3.5 Mg
Manufactured by :Dr.Reddys

NOTE:- Myezom is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug...............

Targeted Therapy for Blood Cancers

MYEZOM BORTEZOMIB 2 MG INJECTION is specifically formulated to target and interfere with cancer cell growth in patients diagnosed with Multiple Myeloma and Mantle Cell Lymphoma. By inhibiting proteasome activity, it disrupts the cellular processes vital for cancer cell survival and proliferation, delivering a focused approach to anticancer therapy.

Safe Handling and Administration

This medication is cytotoxic and requires careful handling by medical professionals. MYEZOM is supplied as a single-use vial containing lyophilized powder that must be reconstituted with an appropriate solvent prior to administration. Both intravenous and subcutaneous routes are used, as directed by a physician, ensuring safe and effective dosage delivery.

Storage and Shelf Life

MYEZOM should be stored at temperatures below 25C and protected from direct sunlight to maintain its effectiveness. The product has a shelf life of 24 months from the date of manufacture, provided it is properly sealed and stored according to the manufacturers guidelines. Always check expiry before use.

FAQs of MYEZOM BORTEZOMIB 2 MG INJECTION:

Q: How should MYEZOM BORTEZOMIB 2 MG INJECTION be administered?

A: MYEZOM should be reconstituted with an appropriate solvent by a healthcare professional and administered either intravenously or subcutaneously as prescribed by your doctor.

Q: What is the main use of MYEZOM BORTEZOMIB INJECTION?

A: It is used for the treatment of adults with Multiple Myeloma and Mantle Cell Lymphoma, acting as an anticancer agent in these hematological conditions.

Q: When should the injection be given?

A: The timing and frequency of administration are determined by your treating physician based on your medical condition and treatment schedule. Always follow your doctors instructions closely.

Q: Where should MYEZOM INJECTION be stored?

A: Store the vial below 25C in a dry place, protected from light. Keep MYEZOM out of reach of children and only use if the vial is intact and within the expiry date.

Q: What is the process for preparing MYEZOM before use?

A: Before administration, MYEZOM must be reconstituted with an appropriate sterile solvent by a medical professional, ensuring it is ready for injection as per prescribed guidelines.

Q: What are the benefits of MYEZOM BORTEZOMIB INJECTION?

A: The primary benefit is its effectiveness in inhibiting cancer cell growth in conditions like Multiple Myeloma and Mantle Cell Lymphoma, offering a targeted treatment option that can improve patient outcomes when used correctly.

Q: Is a prescription required to obtain MYEZOM BORTEZOMIB INJECTION?

A: Yes, MYEZOM is a prescription-only medicine and should be used under strict medical supervision due to its cytotoxic nature and specific dosing requirements.

Tell us about your requirement